Je dividenda Eurofins Scientific bezpečná?
Eurofins Scientific zvyšuje dividendu již 12 let.
V průběhu posledních 10 let Eurofins Scientific tuto hodnotu zvyšovala o 25,893 % ročně zvýšen.
Na pětiletou perspektivu vzrostl výplata o 33,032 %.
Analytici počítají pro běžný obchodní rok s růstem o Růst dividend ve výši 4,358%.
Eurofins Scientific Aktienanalyse
Co dělá Eurofins Scientific?
Eurofins Scientific SE is a leading group of laboratories specializing in providing testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. The company was founded in 1987 by Dr. Gilles Martin and is headquartered in Luxembourg. It has since become one of the largest laboratory service providers worldwide.
Eurofins' business model is based on a wide range of analytical services that enable customers to monitor product quality, process safety, and regulatory compliance. Eurofins offers a comprehensive range of tests, including food and feed testing, residue analysis, hygiene and contamination analysis, environmental analysis, and genetic testing.
The group operates more than 800 laboratories in 47 countries and employs more than 50,000 people. Eurofins has a strong presence in Europe, North America, and the Asia-Pacific region, and is active in various industries such as agriculture and food, environment and pharmaceuticals, as well as clinical diagnostics and forensics.
The different divisions of Eurofins are tailored to the specific needs of its customers. For example, the "Food Testing" division offers a wide range of tests to ensure that food is safe and healthy. Thanks to these tests, manufacturers can ensure that their products comply with legal requirements and meet customer needs.
Another division of Eurofins is "Environment Testing," which offers tests and analyses for a variety of environmental samples. These enable companies to monitor compliance with environmental regulations, identify environmental issues, and improve their environmental footprint.
Eurofins' Biopharma division offers a variety of testing services for the biopharmaceutical industry, including clearance studies, cleaning validation, particle measurements, and DNA sequencing.
In the field of clinical diagnostics, Eurofins provides laboratory services to improve diagnoses and treatments. These include genetic testing, oncology tests, prenatal diagnostics, and infectious diseases.
Another important business area for Eurofins is forensics, which benefits from the latest developments in DNA analysis as well as analysis methods for detecting drugs, alcohol, and toxic substances. The services provided by Eurofins include forensic wildlife investigations and the identification of human and animal species based on DNA samples.
In addition to the aforementioned business areas, Eurofins also offers a wide range of services such as consulting, audits, and training to help improve its customers' performance and help them achieve their business goals.
In conclusion, Eurofins Scientific SE is a leading provider of testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. With its specialized services, the company enables its customers to monitor product quality, process safety, and regulatory compliance. Eurofins' various divisions offer tests and analyses for a variety of industries, contributing to improving its customers' businesses. Eurofins Scientific je jednou z nejoblíbenějších společností na Eulerpool.com.Akciové spořicí plány nabízí atraktivní možnost pro investory, jak dlouhodobě budovat jmění. Jednou z hlavních výhod je takzvaný průměrovací efekt nákladů: Pravidelnou investicí fixní částky do akcií nebo akciových fondů se automaticky nakupuje více podílů, když jsou ceny nízké, a méně, když jsou vysoké. To může vést k výhodnější průměrné ceně za podíl v průběhu času. Akciové spořicí plány navíc umožňují i malým investorům přístup k drahým akciím, protože se mohou zúčastnit už s malými částkami. Pravidelná investice také podporuje disciplinovanou investiční strategii a pomáhá vyhýbat se emočním rozhodnutím, jako je impulzivní nákup nebo prodej. Kromě toho investoři profitují z potenciálního zhodnocení akcií a z výplat dividend, které mohou být reinvestovány, což zvyšuje efekt složeného úroku a tím růst investovaného kapitálu.